top of page
  • GenomeWeb

Circular Genomics Readying to Launch Zoloft Response Diagnostic Based on Circular RNA Biomarker

NEW YORK, NY., July 27, 2023 (GenomeWeb) -- Molecular diagnostics startup Circular Genomics has identified a new biomarker that can predict which patients are likely to respond to Pfizer's antidepressant Zoloft (Sertraline).

51 views0 comments


Commenting has been turned off.
bottom of page